Coverage
-
June 30, 2016
An Illinois federal judge held Wednesday that Racketeer Influenced and Corrupt Organizations Act claims over Abbott Laboratories' alleged off-label promotion of seizure drug Depakote fail because two health benefit plans didn't show a sufficiently direct link between the company's misrepresentations and their injuries.
1 other articles on this case.
View all »